1. Home
  2. TORO vs STXS Comparison

TORO vs STXS Comparison

Compare TORO & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Corp.

TORO

Toro Corp.

HOLD

Current Price

$6.10

Market Cap

174.5M

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.43

Market Cap

164.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TORO
STXS
Founded
2022
1990
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.5M
164.1M
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
TORO
STXS
Price
$6.10
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
22.4K
812.4K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
36.86%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.64
$1.24
52 Week High
$8.50
$3.59

Technical Indicators

Market Signals
Indicator
TORO
STXS
Relative Strength Index (RSI) 72.65 47.96
Support Level $4.87 $1.30
Resistance Level $8.50 $1.97
Average True Range (ATR) 0.38 0.08
MACD 0.05 0.02
Stochastic Oscillator 74.02 64.29

Price Performance

Historical Comparison
TORO
STXS

About TORO Toro Corp.

Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: